The abundance of gut microbiota, the content of products generated by microbial biochemical reactions, and the content of bacterial enzymes are used as methods for detecting disease risk.
Patent Information
- Application Number
- TW114131395
- Authority / Receiving Office
- TW · TW
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2025-08-18
- Publication Date
- 2026-11-11
- Estimated Expiration
- 2045-08-17
Abstract
Claims
1. A method for in vitro detection of disease risk, comprising detecting and analyzing the abundance of a microorganism, a gut microbiota biochemical reaction, and the content of a bacterial enzyme in a fecal sample. When the abundance of the microorganism, the gut microbiota biochemical reaction, and the bacterial enzyme content in the fecal sample are significantly higher than the corresponding indicators in a fecal sample from a healthy population, the fecal sample provider is determined to be at risk of the disease; the disease is Parkinson's Disease (PD); the microorganism includes: Megasphaera elsdenii, Phascolarctobacterium faecium, Acidaminococcus intestini, Dryocola boscaweniae, Dialistister massiliensis, Alistipes putredinis, and Desulfovibrio porci; The biochemical reactions of this intestinal bacteria include: dolicol and dolichyl phosphate biosynthesis and dimethyl sulfide degradation I; the bacterial enzymes include: dehydrodolichyl diphosphate synthase, polyprenol reductase, dolicol kinase, dissimilatory dimethyl-sulfide monooxygenase, and methanethiol oxidase.
2. The method for in vitro detection of disease risk as described in claim 1, which uses a long-fragment gene sequence to analyze the abundance of microorganisms in the gut, intestinal biochemical reactions, and the content of bacterial enzymes.
Citation Information
Patent Citations
Methods and materials for determining parkinson's disease or a risk thereof
WO2021260276A1
